Skip to content

Subconjunctival Hemorrhage

BASICS

  • Definition: Bleeding from small vessels beneath the conjunctiva (the thin clear skin over the sclera).
  • Clinical: Appears as well-demarcated, bright red patches under the conjunctiva; can be flat, elevated, or bullous.
  • Course: Self-resolves in days to weeks depending on severity.

EPIDEMIOLOGY

  • Common: 3% diagnosis rate in ophthalmology clinics.
  • Increased Incidence:
  • With age
  • Contact lens wearers (5%)
  • Systemic diseases: diabetes, hypertension, coagulation disorders
  • Trauma
  • More common in summer (possibly trauma-related)

ETIOLOGY & PATHOPHYSIOLOGY

  • Mechanism: Damage to conjunctival/episcleral vessels from direct or indirect injury.
  • Risk factors: Anticoagulated states, blood dyscrasias, thrombocytopenia, anemia, antiplatelet/anticoagulant use.
  • Causes:
  • Idiopathic (most common)
  • Trauma (blunt/penetrating, contact lenses, eye rubbing, foreign body, ocular procedures)
  • Valsalva (coughing, sneezing, vomiting, straining, heavy lifting)
  • Ocular surface infection (esp. viral)
  • Systemic disease: HTN, diabetes, atherosclerosis
  • Age associations:
  • <40 yrs: trauma, Valsalva, contacts
  • 40 yrs: conjunctivochalasis, pinguecula, systemic disease (esp. HTN >60 yrs)


RISK FACTORS

  • Trauma
  • Age
  • Contact lens use
  • Systemic diseases (HTN, diabetes)
  • Bleeding disorders
  • Recent ocular procedures

GENERAL PREVENTION

  • Avoid rubbing eyes
  • Proper contact lens care
  • Protective eyewear during risky activities
  • Optimize systemic disease control (HTN, diabetes, thrombocytopenia)
  • Monitor PT/INR if on warfarin

DIAGNOSIS

HISTORY

  • Noticed by patient or others as β€œred eye”
  • Usually painless, no vision changes or photophobia
  • Possible mild irritation or foreign body sensation
  • Key questions: trauma, contact lens use, Valsalva, systemic disease, meds (antiplatelets, anticoagulants)

PHYSICAL EXAM

  • Visual acuity, IOP, pupils: Normal
  • Slit lamp: Bright red, sharply demarcated patch under conjunctiva (often inferior)
  • Color changes: Bright red (fresh), darkens, then yellow as resorbs
  • Fluorescein: No uptake with simple SCH
  • BP: Measure for underlying HTN
  • Older adults: Lesion may be more widespread
  • ALERT: If concern for globe rupture, immediate ophthalmology referral

DIFFERENTIAL DIAGNOSIS

  • Conjunctivitis (viral, bacterial, allergic, chemical)
  • Foreign body
  • Trauma (penetrating/perforating)
  • Ocular surgery/injection
  • Contact lens-related injury
  • Child abuse (bilateral in infants/toddlers)
  • Birth trauma (newborns)

DIAGNOSTIC TESTS & INTERPRETATION

  • Clinical diagnosis – rarely need testing
  • Fluorescein: No uptake unless abrasion/laceration
  • CT: Only if suspect orbital fracture or foreign body
  • CBC, PT/INR: If bleeding disorder suspected

ALERT: Avoid MRI if metallic foreign body possible


TREATMENT

  • Reassurance – SCH is benign and self-limited
  • Artificial tears for irritation (up to QID as needed)
  • Control underlying factors: BP, glucose, INR
  • Protective eyewear if indicated

ISSUES FOR REFERRAL

  • Any significant trauma (even blunt)
  • Vision changes, pain, new floaters, or abnormal pupil response
  • Lack of resolution in 2 weeks or recurrent SCH

ONGOING CARE

  • Follow-up: Only if unresolved or recurrent
  • Work up for systemic cause if recurrent

PATIENT EDUCATION

  • Reassure: Self-limited, resolves in 1–2 weeks
  • Return if area does not resolve or recurs
  • Proper contact lens hygiene
  • Artificial tears for comfort

PROGNOSIS

  • Excellent – virtually all cases resolve without sequelae

COMPLICATIONS

  • Rare

ICD-10

  • H11.30: Conjunctival hemorrhage, unspecified eye
  • H11.31: Conjunctival hemorrhage, right eye
  • H11.32: Conjunctival hemorrhage, left eye

CLINICAL PEARLS

  • SCH is a clinical diagnosis; typically asymptomatic and self-resolving.
  • Risk factors: trauma, Valsalva, HTN, diabetes.
  • Immediate referral for pain, vision changes, abnormal pupil, or suspected penetrating injury.
  • Mainstays: reassurance and ocular lubrication.